circRNA basic information
circBase ID: hsa_circ_0004662
Name: hsa_circ_SOD2
Synonym: circRNA superoxide dismutase 2
Host Gene: SOD2
Genomic location(hg19): chr6:160103505-160109274:-
Genomic location(hg38): chr6:159682473-159688242:-
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

HCC samples; normal controls; HCC tissues; normal tissues

Cell lines:

THLE-2; Hep3B; HuH-7

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: ANXA11, Ago2, CD8 + T cell, PD-1, MMP2, MMP9
Associated microRNA: miR-497-5p
Biological function: CircSOD2 promotes HCC cell proliferation, colony formation, cell cycle progression, migration, invasion, metastasis, tumor growth, immune evasion and anti-PD-1 resistance, and inhibits apoptosis and CD8 + T cell viability.
Molecular mechanism: CircSOD2 acts as a miR-497-5p sponge to upregulate ANXA11 expression, thereby promoting HCC progression, immune evasion and anti-PD-1 resistance.
Biological pathway or process:

ceRNA regulation (promotes); proliferation (promotes); apoptosis (inhibits); cell cycle (promotes); migration (promotes); invasion (promotes); metastasis (promotes); immune regulation (promotes); drug resistance (promotes)

Detected method:
Q
S
Validation methods:

RT-qPCR; circRNA-seq; Actinomycin D / DRB Stability Assay; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Transfection; MTT; Colony Formation Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Wound Healing Assay; Transwell Assay; Western Blot; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); IHC (Immunohistochemistry); In Vivo Animal Model; Bioinformatics Analysis

Clinical significance:

CircSOD2 may be a biomarker for immune evasion and anti-PD-1 resistance and may contribute to HCC diagnosis and immunotherapeutic effect.

Description:

CircSOD2 is upregulated in HCC tissues and cell lines and functions as an oncogenic circRNA. It promotes HCC growth, metastasis, immune evasion and anti-PD-1 resistance by sponging miR-497-5p and increasing ANXA11 expression. Its high expression is associated with reduced CD8 + T cell frequency and potential immunotherapeutic resistance.

Confidence score:

0.8572

Other information
Title:

CircSOD2 Contributes to Tumor Progression, Immune Evasion and Anti-PD-1 Resistance in Hepatocellular Carcinoma by Targeting miR-497-5p/ANXA11 Axis.

Journal: Biochemical genetics
Published: 2023
PubMed ID: 36008700
Study type:

combined biological and clinical study

Data availability: The datasets used and analyzed during the current study are available from the corresponding author on reasonable request; supplementary material available at https:// doi. org/ 10. 1007/ s10528-022-10273-w
Code availability: -